To legally market a new tobacco product in the United States, a company must receive a written marketing order from FDA. These applications include clinical studies on subjects conducted to evaluate the impact of tobacco products on individual health. Clinical reports are written on these studies These clinical reports typically follow Good Clinical Practice guidelines and the clinical reports follow ICH: Guideline for Industry Structure and Content of Clinical Study Reports.
Data collection and Data Tabulation standards have been developed in this guide and are described in Section X ????. These standards are based on the SDTM Model. The SDTM model has been designed to represent the broadest range of human and animal study data in a standardized manner. This SDTM Model document ( REF ) describes the basic concepts and general structure of the model. Individual implementation guides (IGs) have also been created to provide detail specification and recommendations for representing data commonly collected. The Study Data Tabulation Model Implementation Guide for Human Clinical Trials (SDTMIG) https://www.cdisc.org/standards/foundational/sdtmig provides useful guidelines for creating data tabulations for Human Clinical Trials. Since, data tabulations and clinical study reports on tobacco products are operationally similar to data tabulations and clinical study reports prepared for Human Clinical Trials, the SDTMIG was employed in developing this section.
Overview
Content Tools